These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11375327)

  • 1. Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice.
    Abiru N; Maniatis AK; Yu L; Miao D; Moriyama H; Wegmann D; Eisenbarth GS
    Diabetes; 2001 Jun; 50(6):1274-81. PubMed ID: 11375327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
    Elias D; Marcus H; Reshef T; Ablamunits V; Cohen IR
    Eur J Immunol; 1995 Oct; 25(10):2851-7. PubMed ID: 7589082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of insulin autoantibodies and protection from diabetes with subcutaneous insulin B:9-23 peptide without adjuvant.
    Liu E; Abiru N; Moriyama H; Miao D; Eisenbarth GS
    Ann N Y Acad Sci; 2002 Apr; 958():224-7. PubMed ID: 12021111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.
    Nakayama M; Beilke JN; Jasinski JM; Kobayashi M; Miao D; Li M; Coulombe MG; Liu E; Elliott JF; Gill RG; Eisenbarth GS
    J Clin Invest; 2007 Jul; 117(7):1835-43. PubMed ID: 17607359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23.
    Liu E; Moriyama H; Abiru N; Miao D; Yu L; Taylor RM; Finkelman FD; Eisenbarth GS
    J Clin Invest; 2002 Oct; 110(7):1021-7. PubMed ID: 12370280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes.
    Devendra D; Paronen J; Moriyama H; Miao D; Eisenbarth GS; Liu E
    J Autoimmun; 2004 Aug; 23(1):17-26. PubMed ID: 15236749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).
    Daniel D; Wegmann DR
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):956-60. PubMed ID: 8570667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides derived from murine insulin are diabetogenic in both rats and mice, but the disease-inducing epitopes are different: evidence against a common environmental cross-reactivity in the pathogenicity of type 1 diabetes.
    Heath VL; Hutchings P; Fowell DJ; Cooke A; Mason DW
    Diabetes; 1999 Nov; 48(11):2157-65. PubMed ID: 10535449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prevention of diabetes and marked suppression of insulin autoantibodies and insulitis in mice lacking native insulin B9-23 sequence.
    Nakayama M; Babaya N; Miao D; Gianani R; Liu E; Elliott JF; Eisenbarth GS
    Ann N Y Acad Sci; 2006 Oct; 1079():122-9. PubMed ID: 17130542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathways altered by insulin b9-23 immunization.
    Eckenrode SE; Ruan QG; Collins CD; Yang P; McIndoe RA; Muir A; She JX
    Ann N Y Acad Sci; 2004 Dec; 1037():175-85. PubMed ID: 15699514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration.
    Hutchings P; Cooke A
    J Autoimmun; 1998 Apr; 11(2):127-30. PubMed ID: 9650091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice.
    Levisetti MG; Lewis DM; Suri A; Unanue ER
    Diabetes; 2008 Jul; 57(7):1852-60. PubMed ID: 18398138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
    Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
    Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse.
    Liu E; Moriyama H; Paronen J; Abiru N; Miao D; Yu L; Taylor RM; Eisenbarth GS
    J Autoimmun; 2003 Nov; 21(3):213-9. PubMed ID: 14599846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-serum with anti-autoantibody activity decreases autoantibody-positive B lymphocytes and type 1 diabetes of female NOD mice.
    Luan L; Xue R; Lu C; Cui A; Hou Y; Quan J; Xiang M; Wang X; Yuan W; Sun N; Meng D; Chen S
    Autoimmunity; 2016; 49(1):21-30. PubMed ID: 26334951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
    Vaysburd M; Lock C; McDevitt H
    J Exp Med; 1995 Sep; 182(3):897-902. PubMed ID: 7650494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice.
    Zhang L; Stadinski BD; Michels A; Kappler JW; Eisenbarth GS
    Diabetes Metab Res Rev; 2011 Nov; 27(8):784-9. PubMed ID: 22069260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
    Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
    J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
    Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
    Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo expression of B:9-23 peptide/I-A(g7) complex may abrogate the inhibition of diabetes induced by RGD-fiber-mutant adenovirus in NOD mice.
    Abiru N; Sun F; Kawasaki E; Yamasaki H; Oshima K; Nagayama Y; Mizuguchi H; Hayakawa T; Miao D; Liu E; Eisenbarth GS; Eguchi K
    Ann N Y Acad Sci; 2003 Nov; 1005():218-21. PubMed ID: 14679063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.